share_log

Cellares, The First Integrated Development And Manufacturing Organization (IDMO), Has Concluded The Technology Adoption Program (TAP) On Its Automated Cell Therapy Manufacturing Cell Shuttle For Resecabtagene Autoleucel, (Rese-cel, Previously Known As...

Benzinga ·  Mar 19 11:02

Cellares, The First Integrated Development And Manufacturing Organization (IDMO), Has Concluded The Technology Adoption Program (TAP) On Its Automated Cell Therapy Manufacturing Cell Shuttle For Resecabtagene Autoleucel, (Rese-cel, Previously Known As CABA-201)

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 270

Recommended

Write a comment